Aziyo Biologics (NASDAQ:AZYO – Get Rating) is set to post its quarterly earnings results after the market closes on Thursday, August 11th. Analysts expect Aziyo Biologics to post earnings of ($0.55) per share for the quarter. Aziyo Biologics has set its FY 2022 guidance at EPS.Individual that wish to register for the company’s earnings conference call can do so using this link.
Aziyo Biologics (NASDAQ:AZYO – Get Rating) last released its earnings results on Monday, May 9th. The company reported ($0.60) EPS for the quarter, topping analysts’ consensus estimates of ($0.62) by $0.02. The company had revenue of $11.50 million for the quarter, compared to analysts’ expectations of $10.77 million. Aziyo Biologics had a negative return on equity of 260.23% and a negative net margin of 60.68%. During the same period in the previous year, the business posted ($0.50) EPS. On average, analysts expect Aziyo Biologics to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Aziyo Biologics Stock Down 1.5 %
AZYO stock opened at $6.50 on Thursday. The company has a quick ratio of 1.14, a current ratio of 1.50 and a debt-to-equity ratio of 1.34. The firm has a market capitalization of $88.13 million, a PE ratio of -2.64 and a beta of -0.70. Aziyo Biologics has a twelve month low of $4.10 and a twelve month high of $9.76. The stock has a 50-day simple moving average of $6.39 and a two-hundred day simple moving average of $6.19.
Analysts Set New Price Targets
Aziyo Biologics Company Profile
Aziyo Biologics, Inc, a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device.
- Get a free copy of the StockNews.com research report on Aziyo Biologics (AZYO)
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- There Are Different Types of Stock To Invest In
- PayPal Continues To Struggle As Competition Increases
- Is Starbucks Shooting For The Moon?
- Two High-Yield Deep-Values You Shouldn’t Ignore
Receive News & Ratings for Aziyo Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aziyo Biologics and related companies with MarketBeat.com's FREE daily email newsletter.